Modeling Therapeutic Benefit in the Midst of Uncertainty: Therapy for Hepatitis C

Digestive Diseases and Sciences

Volumn 41, Issue 12 SUPPL., 1996, Pages

  Bennett, William G ^b   Pauker, Stephen G ^b   Davis, Gary L ^b   Wong, John B ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Cost effectiveness analysis; Decision analysis; Decision making; Hepatitis C; Interferon

Indexed keywords

ALPHA2B INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL;

CHRONIC DISEASE; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HEALTH CARE COSTS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; QUALITY OF LIFE; VALUE OF LIFE;

EID: 0030481064     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
2. Davis GL, Lau JYN, Lim HL: Therapy for chronic hepatitis C. Gastroenterol Clin North Am 23:603-613, 1994
3. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH, Alter HJ: Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675, 1990
4. Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB, Gitnick G, Knodell RG, Perrillo RP, Stevens CE, Hollingsworth CG, and the National Heart, Lung, and Blood Institute Study Group: Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 327:1906-1911, 1992
5. Dusheiko GM, Roberts GA: Treatment of chronic type B and C hepatitis with alpha interferon: An economic appraisal. Hepatology 22:1863-1873, 1995
6. Shiell A, Briggs A, Farrell GC: The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C. Med J Aust 160:268-272, 1994
7. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, and the Hepatitis Interventional Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med 321:1501-1506, 1989
8. Kleter GEM, Brouwer JT, Heijtink RA, Schalm SW, Quint WGV: Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferon. Antimicrob Agents Chemother 37:595-597, 1993
9. Nishiguchi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S: Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346:1051-1055, 1995
10. Saracco G, Rosina F, Torrani Cerenzia MR, Lattore V, Chiandussi L, Gallo V, Petrino R, De Micheli AG, Donegani E, Solinas A, Deplano A, Tocco A, Cossu P, Pintus C, David E, Mazzucco G, Verme G, Rizzetto M: A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis. J Hepatol 11(suppl 1):S43-S49, 1990
11. Takahashi M, Yamada G, Miyamoto R, Doi T, Endo H, Tsuji T: Natural course of chronic hepatitis C. Am J Gastroenterol 88:240-243, 1993
12. Tremolada F, Casarin C, Alberti A, Drago C, Tagger A, Rihero ML, Realdi G: Long-term follow-up of non-A, non-B (type C) posttransfusion hepatitis. J Hepatol 16:273-281, 1992
13. Mattsson L: Chronic non-A, non-B hepatitis with special reference to the transfusion-associated form. Scand J Infect Dis 59(suppl):1-55, 1989
14. Fattovich G: Risk factors for hepatic decompensation and hepatocellular carcinoma in patients with HbsAg-positive compensated cirrhosis. In: European Study Group on Viral Hepatitis (Eurohep), Report of the Seventh Eurohep Workshop; February 12-13, 1993, Paris, The Wellcome Foundation, 1993
15. Columbo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, Donato MF, Piva A, Di Carlo V, Dioguardi N: Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 325:675-680, 1991
16. Beck JR, Kassirer JP, Pauker SG: A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med 73:883-888, 1982
17. Beck JR, Pauker SG, Gottlieb JE, Klein K, Kassirer JP: A convenient approximation of life expectancy ("the DEALE"). II. Use in medical decision-making. Am J Med 73:889-897, 1982
18. Beck JR, Pauker SG: The Markov process in medical prognosis. Med Decis Making 3:419-458, 1983
19. Sonnenberg FA, Beck JR: Markov models in medical decision making: A practical guide. Med Decis Making 13:322-338, 1993
20. Finkler SA: The distinction between cost and charges. Ann Intern Med 96:102-109, 1982
21. Wong JB, Koff RS, Tinè F, Pauker SG: Cost-effectiveness of interferon α-2b treatment for hepatitis B antigen-positive chronic hepatitis B. Ann Intern Med 122:664-675, 1995
22. Goldman L, Gordon DJ, Rifkind BM, Hulley SB, Detsky AS, Goodman DS, Kinosian B, Weinstein MC: Cost and health implications of cholesterol lowering. Circulation 85:1960-1968, 1992
23. Wong JB, Sonnenberg FA, Salem DN, Pauker SG: Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Ann Intern Med 113:852-871, 1990
24. Sisk JE, Riegelman RK: Cost effectiveness of vaccination against pneumococcal pneumonia: An update. Ann Intern Med 104:79-86, 1986
25. Wagner JL, Herdman RC, Wadhwa S: Cost effectiveness of colorectal cancer screening in the elderly. Ann Intern Med 115:807-817, 1991
26. Eisenstaedt RS, Getzen TE: Screening blood donors for human immunodeficiency virus antibody: cost-benefit analysis. Am J Public Health 78:450-454, 1988
27. Eddy DM: Screening for breast cancer. Ann Intern Med 111:389-399, 1989